PT - JOURNAL ARTICLE AU - Nandini Sharma AU - Pragya Sharma AU - Saurav Basu AU - Sonal Saxena AU - Rohit Chawla AU - Kumar Dushyant AU - Nutan Mundeja AU - Z SK Marak AU - Sanjay Singh AU - Gautam Kumar Singh AU - Ruchir Rustagi TI - The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study AID - 10.1101/2020.12.13.20248123 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.13.20248123 4099 - http://medrxiv.org/content/early/2020/12/14/2020.12.13.20248123.short 4100 - http://medrxiv.org/content/early/2020/12/14/2020.12.13.20248123.full AB - Background Three rounds of a repeated cross-sectional serosurvey to estimate the seroprevalence and trends of SARS-CoV-2 were conducted from August-October’ 2020 in the state of Delhi in India in the general population aged ≥5 years.Methods The selection of participants was through a multi-stage sampling design from all the 11 districts and 280 wards of the city-state, with two-stage allocation proportional to population- size. Household selected was via systematic random sampling, and individual participant selection through the age-order procedure. The blood samples were screened using the IgG ELISA COVID-Kawach kit (August Round), and the ERBALISA COVID-19 IgG (September and October) rounds. The seroprevalence was estimated by applying the sampling weights based on age and sex with further adjustment for the assay-kit characteristics.Results A total of 4267 (n=15046), 4311 (n=17409), and 3829 (n=15015) positive tests indicative of the presence of IgG antibody to SARS-CoV-2 were observed during the August, September, and October 2020 serosurvey rounds, respectively. The adjusted seroprevalence declined from 28.39% (95% CI 27.65-29.14) (August) to 24.08% (95% CI 23.43-24.74) (September), and 24.71% (95% CI 24.01, 25.42%) (October). The antibody positivity was highest in the ≥50 and female age-group during all rounds of the serosurvey, while the decline was maximum among the younger age-group (5-17 years). On adjusted analysis, participants with lower per capita income, living in slums or overcrowded households, and those with diabetes comorbidity had significantly higher statistical odds of antibody positivity.Conclusions Despite high IgG seroprevalence, there was evidence for waning of antibody positivity with the progression of the COVID-19 epidemic, implying a potential reduction in population immunity, especially if also associated with the lack of trained T cell immunity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The logistics and human resources were deputed by the Directorate General of Health Services, Government of National Capital Territory, Delhi.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics Committee, Maulana Azad Medical College & Associated Hospitals, 2 BSZ Marg, New Delhi - 110002 F.1/IEC/MAMC/(78/06/2020/No.176)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe anonymized dataset would be made available on reasonable request to the corresponding author after publication of the article.